ArticleLeukemia2021

Downregulation of MTSS1 in acute myeloid leukemia is associated with a poor prognosis, chemotherapy resistance, and disease aggressiveness.

Alexander Michael Grandits et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.